STALICLA SA

Altamira Therapeutics is developing and supplying peptide-based nanoparticles for efficient RNA delivery to extrahepatic tissues. Our versatile OligoPhore™ and SemaPhore™ platforms are suited for siRNA, antisense oligonucleotides, mRNA and other RNA modalities and enable strong endosomal release.

SYRHATECH is a Swiss company developing and manufacturing hyaluronic acide-based medical devices. We offer CDMO activities with a high level of performance, quality and competence. Our customers come to entrust us with their projects in the fields of dermatology, ophthalmology, and many others.